Variable | Non-DM (n = 184) | Short-DM (n = 64) | Long-DM (n = 31) | P value | PNon vs. Short | PShort vs. Long | PNon vs. Long |
---|---|---|---|---|---|---|---|
Age, years | 57.5 ± 11.6 | 55.2 ± 11.5 | 61.0 ± 10.5 | 0.063 |  |  |  |
BMI, kg/m2 | 25.8 ± 4.0 | 27.1 ± 3.4 | 26.1 ± 2.8 | 0.072 |  |  |  |
Men | 152 (82.6) | 50 (78.1) | 27 (87.1) | 0.586 | Â | Â | Â |
Smoking | 127 (69.0) | 43 (67.2) | 24 (77.4) | 0.623 | Â | Â | Â |
Medical history | |||||||
 Hypertension | 102 (55.4) | 41 (64.1) | 20 (64.5) | 0.378 |  |  |  |
 Dyslipidemia | 168 (91.3) | 56 (87.5) | 29 (93.5) | 0.630 |  |  |  |
 Prior PCI | 12 (6.5) | 5 (7.8) | 4 (12.9) | 0.388 |  |  |  |
Laboratory findings | |||||||
 White blood cell count, × 106/L | 10.6 ± 3.2 | 10.9 ± 3.2 | 10.0 ± 2.7 | 0.624 |  |  |  |
 Hs-CRP, mg/L | 5.3 (2.4, 10.9) | 6.6 (2.9, 10.3) | 4.0 (2.6, 10.6) | 0.840 |  |  |  |
 eGFR, mL/min/1.73 m2 | 97.3 (77.7, 114.3) | 99.9 (88.2, 119.1) | 93.2 (77.8, 107.3) | 0.119 |  |  |  |
 HbA1c,  % | 5.7 (5.5, 5.9) | 7.6 (6.8, 8.9) | 8.4 (7.7, 9.8) | < 0.001* | < 0.001* | 0.001* | < 0.001* |
 TC, mg/dL | 164.0 (139.2, 195.2) | 172.1 (155.8, 203.2) | 175.9 (130.7, 205.0) | 0.172 |  |  |  |
 TG, mg/dL | 114.7 (73.7, 167.8) | 154.5 (104, 215.8) | 144.3 (90.3, 206.3) | 0.001* | 0.006* | 0.996 | 0.046 |
 LDL-C, mg/dL | 104 (82.6, 127.5) | 114.5 (95.3, 133.0) | 103.6 (78.9,128.4) | 0.279 |  |  |  |
 HDL-C, mg/dL | 41.4 (35.6, 48.3) | 39.3 (35.3, 45.7) | 39.8 (34.8, 47.6) | 0.417 |  |  |  |
 Lipoprotein (a), mg/L | 179.8 (84.5, 393) | 107.5 (49,311.4) | 149.0 (87.1, 315.0) | 0.825 |  |  |  |
 LVEF, % | 54.7 ± 6.5 | 56.6 ± 5.2 | 53.9 ± 5.4 | 0.062 |  |  |  |
Prior medications | |||||||
 Aspirin | 64 (34.8) | 29 (45.3) | 12 (38.7) | 0.310 |  |  |  |
 P2Y12 inhibitor | 43 (23.4) | 17 (26.6) | 11 (35.5) | 0.323 |  |  |  |
 Statin | 34 (18.5) | 8 (12.5) | 5 (16.1) | 0.592 |  |  |  |
DM control | |||||||
 Insulin |  | 5 (7.8) | 11 (35.5) |  |  |  |  |
 Oral hypoglycemic agents |  | 40 (62.5) | 18 (58.1) |  |  |  |  |
 Diet only |  | 19 (29.7) | 2 (6.5) |  |  |  |  |